Kyle Retterer

Current and future perspectives of liquid biopsies in genomics-driven oncology

Artificial intelligence in drug development: present status and future prospects

Towards precision medicine

Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis

Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1

Complex congenital cardiovascular anomaly in a patient with AGO1‐associated disorder

Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation

Identification of novel PIEZO1 variants using prenatal exome sequencing and correlation to ultrasound and autopsy findings of recurrent hydrops fetalis

Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females

Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders

Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort

Whole-exome sequencing on deceased fetuses with ultrasound anomalies: expanding our knowledge of genetic disease during fetal development